No Detail Found!

Research on the combined impact of high-flux dialysis and levocarnitine on the functionality of arteriovenous fistulas in patients undergoing maintenance hemodialysis

Author(s)
Lei Pang Department of Nephrology, Third Affiliated Hospital of Qiqihar Medical College,,China
Shanshan Sun Department of Nephrology, Third Affiliated Hospital of Qiqihar Medical College,,China
Ying Shi Department of Nephrology, Third Affiliated Hospital of Qiqihar Medical College,,China
Xiaoyan Yu Department of Nephrology, Third Affiliated Hospital of Qiqihar Medical College,,China
Na Luo Department of Ultrasound, Third Affiliated Hospital of Qiqihar Medical College,,China
Shuangyu Li Department of Nephrology, Third Affiliated Hospital of Qiqihar Medical College,,China
Abstract
To explore the influence of levocarnitine on arteriovenous fistula (AVF) function in patients undergoing highflux dialysis and delve into its potential mechanisms. Complication Reduction: The treatment group had markedly lower incidences of vascular stenosis (4.69% vs. 20%), thrombosis (3.13% vs. 15%), poor venous return (6.25% vs. 18.33%), and pre-dialysis hypotension (7.81% vs. 23.33%) (all P < 0.05). Hematological Benefits: Significant improvements in hemoglobin (11.57 ± 1.63 vs. 10.38 ± 1.49g/dL) and red blood cell count (3.89 ± 0.51 vs. 3.53 ± 0.46 ×10¹²/L) were observed in the treatment group (P < 0.001), alongside reduced white blood cell counts (6.05 ± 1.49 vs. 6.23 ± 1.60 ×109/L, P = 0.006). Quality of Life: Karnofsky Performance Scale (KPS) scores were significantly higher in the treatment group at both 1-month (P < 0.01) and 3-month follow-ups (P < 0.01). In the context of high-flux hemodialysis, supplementing with levocarnitine can appreciably improve AVF function in ESRD patients, mitigate the occurrence of complications, and potentially enhance the quality of life by alleviating dialysis-related issues. Levocarnitine emerges as a promising adjunctive therapy for patients with compromised AVF function.
Publication Details
Page(s) 781-788
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Arteriovenous fistula, High-flux dialysis, Maintenance hemodialysis, Vascular complications, levocarnitine
References
Abe M,Masakane I,Wada A,Nakai S,Nitta K,Nakamoto H K .2021 .Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study. Clin. Kidney, 15(3) : 473-483.
And Alternative Medicine EC .2023 .Retracted: Effects of high flux hemodialysis combined with L-carnitine on microinflammation and arteriovenous fistula in maintenance hemodialysis patients. Evidence-based complementary and alternative medicine: eCAM, : 9846504.
Battaglia Y,Shroff R,Meijers B,Nistor I,Alfano G,Franssen C,Luyckx V,Liakopoulos V,Mantovani A,Baciga F,Caccia F,Momentè C,Davenport A,Blankestijn PJ,Covic A,Combe C,Basile C C .2025 .Nephrology, dialysis, transplantation: official publication of the European Dialysis. Advance online publication., : .
Bignardi PR,Delfino VDA .2024 .Is hemodiafiltration superior to high-flow hemodialysis in reducing all-cause and cardiovascular mortality in kidney failure patients? A meta-analysis of randomized controlled trials. Hemodialysis international. Hemodial Int, 28(2) : 139-147.
Caskey FJ,Procter S,MacNeill SJ,Wade J,Taylor J,Rooshenas L,Liu Y,Annaw A,Alloway K,Davenport A,Power A,Farrington K,Mitra S,Wheeler DC,Law K,Lewis-White H,Ben-Shlomo Y,Hollingworth W,Donovan J,Lane JA .2022 .). The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes. Trials, 23(1) : 532.
Chen CY,Liou HH,Chang MY,Wang HH,Lee YC,Ho LC,Lin TM,Hung SY .2022 .The use of a low-flux hemo-dialyzer is associated with impaired platelet aggregation in patients undergoing chronic hemodialysis. Medicine, 101(43) : e31623.
Chi XG,Ma Z,Zhang WB,Cai Q,Chen YZ,Ding DL .2021 .Effects of high-flux hemodialysis combined with levocarnitine on vascular calcification, microinflammation, hepcidin, and malnutrition of elderly patients on maintenance hemodialysis. Ann. Palliat. Med, 10(3) : 3286-3298.
De Schuyter K,Colin PJ,Vanommeslaeghe F,Delanghe S,De Cock P,Veys N,De Paepe P,Van Biesen W,Eloot S W .2021 .Optimizing amoxicillin/clavulanic acid dosing regimens in patients on maintenance high-flux hemodialysis. Am J Kidney Dis., 78(1) : 153-156.
Huang W,Bai J,Zhang Y,Qiu D,Wei L,Zhao C,Ren Z,Wang Q,Ren K,Cao N K .2024 .Effects of low-flux and high-flux hemodialysis on the survival of elderly maintenance hemodialysis patients. Ren, 46(1) : 2338217.
Kim HJ,Seong EY,Lee W,Kim S,Ahn HS,Yeom J,Kim K,Kwon CH,Song SH .2021 .Comparative analysis of therapeutic effects between medium cut-off and high flux dialyzers using metabolomics and proteomics: exploratory, prospective study in hemodialysis. Sci. Rep, 11(1) : 17335.
Lim JH,Park Y,Yook JM,Choi SY,Jung HY,Choi JY,Park SH,Kim CD,Kim YL,Cho JH .2020 .Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients. Sci. Rep, 10(1) : 7780.
Morgans HA,Chadha V,Warady BA .2021 .The role of carnitine in maintenance dialysis therapy. Pediatric nephrology, 36(8) : 2545-2551.
Rehman S,Farhan M,Kumar S,Sarfraz MR,Naveed A,Khan MT,Huq H MT .2025 .Efficacy of intravenous versus oral administration of levocarnitine in maintenance hemodialysis patients: A randomized controlled trial investigating therapeutic approaches to renal anemia. Health Sci. Rep, 8(1) : e70297.
Rehman S,Farhan M,Naveed A,Mahmood S,Khattak MI .2024 .Impact of haemodialysis on plasma carnitine concentrations in haemodialysis patients. JPMA., 74(2) : 294-298.
Rodriguez A,Morena M,Bargnoux AS,Chenine L,LerayMoragues H,Cristol JP,Canaud B .2021 .Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration. Artificial organs, 45(8) : E280-E292.
Takashima H,Maruyama T,Abe M .2021 .Significance of levocarnitine treatment in dialysis patients. Nutrients, 13(4) : 1219.
Wang Y,Gan LY,Yang B,Guan HJ,Zuo L HJ .2023 .High-flux hemodialysis does not increase vitamin B loss compared with Low-flux hemodialysis. JREN., 33(5) : 676-681.
Wardoyo EY,Sari AP,Djojo AY,Sarwono J,Mokoagow MI,Darnindro N,Nasarudin J,Epriliawati M,Manurung A,Iskandar M,Wibisana KA,Widyastuti AAA,Mardiyah R .2022 .Hemoperfusion as an adjuvant therapy in maintenance hemodialysis patients with severe COVID-19: A single centre experience. Acta Med, 54(3) : 444-450.
Yang J,Ke G,Liao Y,Guo Y,Gao X Y .2022 .Efficacy of medium cut-off dialyzers and comparison with highflux dialyzers in patients on maintenance hemodialysis: A systematic review and meta-analysis. Ther Apher Dial., 26(4) : 756-768.
Zakrzewska A,Biedunkiewicz J,Komorniczak M,Jankowska M,Jasiulewicz K,Płonka N,Biedunkiewicz B,Małgorzewicz S,Tarasewicz A,Puchalska-Reglińska E,Siebert J,Dębska-Ślizień A,Tylicki L A .2024 .Intradialytic tolerance and recovery time in different high-efficiency hemodialysis modalities. J. Clin. Med, 13(2) : 326.
Zelenitsky SA,Ariano RE .2022 .An updated vancomycin dosing protocol for initiating therapy in patients undergoing intermittent high-flux hemodialysis. Am J Health Syst Pharm., 79(12) : 1006-1010.
Zhao X,Gan L,Hou FF,Liang X,Chen X,Chen Y,Zuo L Z .2024 .The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients. Ren, 46(1) : 2290922.
Zheng Y,Tang Z,You L,Wu Y,Liu J,Xue J .2020 .Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. Ren, 42(1) : 580-586.
Yang Zhou J,T Zhou J .2020 .The efficacy of L-carnitine in improving malnutrition in patients on maintenance hemodialysis: A meta-analysis. Biosci. Rep, 40(6) : BSR20201639.
0

Citations

0

Downloads

50

Views